🔗 Share this article

Grammy-winning soul vocalist D’Angelo died on October 14 at 51 years old after a personal fight with pancreatic cancer.

“The brilliant light of our household has dimmed his light for us in this life,” his relatives confirmed. “After a prolonged and courageous struggle with the disease, we are deeply saddened to declare that D’Angelo, known to his fans around the world as D’Angelo, has been called home.”

D’Angelo left an indelible mark on music with his innovative modern soul style and collaborations with high-profile artists.

He launched his debut album, “Brown Sugar,” in 1995 to immediate acclaim. The record achieved No. 4 on the R&B charts, earned platinum status soon after, and earned multiple Grammy nominations.

However, it was his sophomore release, “Voodoo,” in the year 2000 that boosted his music career into the stratosphere. The album debuted at the top spot on both Billboard’s Top R&B Albums chart and the main album chart. He won two Grammy Awards: Top R&B Record and Outstanding Male Vocal Performance for “Untitled (How Does It Feel).”

The music video for “Untitled (How Does It Feel)” solidified D’Angelo’s reputation as a icon, albeit a hesitant one, in the cultural zeitgeist. The personal depiction showed the singer, notably bare to his midsection, performing straight into the lens.

D’Angelo retreated from the public eye after releasing Voodoo and publicly struggled with substance abuse. In 2005, he was part of a serious car crash that put him in grave health.

More than a decade later, his third and final album, “Black Messiah” (2014), reaffirmed his lasting popularity with another top chart entry on the R&B chart and a Grammy for Top R&B Record.

Again, in his own mysterious way, D’Angelo made only a few public outings in the following years.

The singer was announced as a headliner for the 2025 music event, but his appearance was canceled, due to an “unforeseen medical delay.”

Although details are sparse about D’Angelo’s well-being in the weeks before his passing, he had apparently been hospitalized for an extended period and in hospice for a fortnight.

D’Angelo’s passing is a stark reminder of the devastating effects of pancreatic malignancy, one of the deadliest and hardest to prevent forms of the disease, on a brilliant talent whose life was cut short.

“We are saddened that he can only provide dear memories with his loved ones, but we are forever thankful for the heritage of extraordinarily moving songs he has left us,” his kin expressed.

Pancreatic Malignancy: Lethal and Rarely Preventable

Pancreatic cancer impacts the pancreas, a tiny gland that produces insulin and plays an essential role in breaking down food, among additional roles. The position and dimensions of the organ in the human system make it more challenging to identify cancer.

Even though pancreatic cancer accounts for only approximately three percent of cancer diagnoses each year in the United States, it is causes 7% of cancer deaths.

Almost 70,000 people will be found to have pancreatic cancer and roughly 52,000 will succumb to the illness in the year 2025.

“This malignancy is one of the deadliest cancers, with an fast-growing mass and dismal outcomes. We have few and poor treatment options, and a smaller window to make a significant difference on the lives of people,” said a cancer specialist.

Because this disease rarely causes initial signs, it’s often diagnosed only once the condition is late-stage. Although a patient has symptoms they are often nonspecific and may be mistaken for a several common illnesses.

“Currently, there is no effective method to identify pancreatic cancer in the initial phases, except for paying attention to physical changes and speaking with your doctor if there are new or unusual signs,” said a medical director.

Common symptoms of pancreatic cancer include:

• discomfort in the stomach or back
• reduced body mass
• yellowing of skin and eyes
• reduced hunger
• brownish urine
• light-colored or greasy stools
• loose stools
• excessive hunger or thirst
• nausea

At age 51, D’Angelo’s demise is an exception, as pancreatic cancer is typically found in individuals in the sixty-five to seventy-five range. However, many cancers, such as this type, have become more common in younger people.

“This disease identified prior to fifty is deemed uncommon, yet concerningly, clinicians are noticing a rising count of younger patients suffering from this condition,” said a specialist.

Genetic Background Impacts Cancer Risk

In the absence of effective screening tools for this malignancy, experts stressed the significance of knowing your family’s health background. Certain risk factors, such as smoking and obesity also play a role in the development of pancreatic cancer.

Black individuals have the highest incidence of this malignancy in the United States and are more prone to be diagnosed with inoperable cancer.

“The first step toward lowering one’s risk of this condition is assessing personal risk factors. People should review their genetic background, hereditary factors, and health issues, such as diabetes, chronic pancreatitis, or obesity that may raise their susceptibility,” advised a specialist.

Inherited genetic elements are linked to as much as 10% of all this malignancy cases. If someone in your household has had this disease, you may want to consider DNA analysis.

“For individuals with a relative’s background of pancreatic cancer or those carrying high risk DNA changes, checking may involve sophisticated scans such as MRI scans or internal ultrasound to find initial alterations in the pancreas,” he clarified.

For those looking to lower their chance, lifestyle changes may have an effect. The best step you can take to lower your risk of pancreatic cancer is to stop tobacco use, and if you don’t smoke, stay away altogether.

Heavy drinking is associated with pancreatitis, a risk factor for pancreatic cancer, so reducing or avoiding alcohol may help reduce your risk.

Controlling your weight or shedding pounds may also aid decrease your susceptibility. Individuals with obesity are 20% more likely to get pancreatic cancer. Pancreatic cancer also is more frequent in those with blood sugar issues, and reducing weight can also reduce the chance of type 2 diabetes.

In spite of pancreatic cancer’s poor prognosis, there is reason for optimism.

“We are doing better with treatments and newer mixed drug treatments. There are emerging targeted therapies that are already making an impact,” remarked a specialist.

For numerous individuals, however, education about this rare but {dev